This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Perrigo, Actavis, others say US states' generic drug antitrust claims are time-barred

( November 22, 2024, 23:31 GMT | Official Statement) -- MLex Summary: Perrigo, Actavis, Amneal, and other pharmaceutical companies filed a motion for judgment against US states’ antitrust claims over generic drug pricing, arguing that they were filed too late. “Plaintiffs filed the third complaint more than four years after the last conduct that plaintiffs allege was illegal, nearly six years after the Department of Justice launched a well-publicized criminal investigation of the conduct at issue, nearly six years after Congress convened hearings about the price increases at issue, and nearly eight years after The New York Times reported on suspicious price increases for generic drugs that plaintiffs now allege were illegally coordinated. Plaintiffs waited too long to file the third complaint,” they said.See attached file. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections